Amanote Research

Amanote Research

    RegisterSign In

Alendronate Prevents Loss of Bone Density Associated With Discontinuation of Hormone Replacement Therapy

Archives of Internal Medicine
doi 10.1001/archinte.163.7.789
Full Text
Open PDF
Abstract

Available in full text

Date

April 14, 2003

Authors
Brynne H. Ascott-EvansNuria GuañabensSeppo KivinenBronwyn G. A. StuckeyClelia H. MagarilKristel VandormaelBeate StychMary E. Melton
Publisher

American Medical Association (AMA)


Related search

Alendronate Prevents Alveolar Bone Loss in Experimental Rat Periodontitis

Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology)
2005English

Hormone Therapy Discontinuation

Menopause
GynecologyObstetrics
2010English

Recovery of Trabecular and Cortical Bone Turnover After Discontinuation of Risedronate and Alendronate Therapy in Ovariectomized Rats

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2008English

Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy

JAMA Internal Medicine
Internal Medicine
2014English

Hormone Replacement Therapy

2010English

Hormone Replacement Therapy:

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2000English

Hormone Replacement Therapy

2015English

Hormone Replacement Therapy

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
1997English

Hormone Replacement Therapy

Drugs and Aging
GerontologyGeriatricsPharmacology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy